Dr. Scott Gottlieb, MD, is an Independent Director at Illumina, Inc., an Independent Director at Pfizer Inc., a Special Partner at NEA Management Co. LLC and a Member at National Academy of Medicine of United States. He is on the Board of Directors at Illumina, Inc., Tempus Labs, Inc., Aetion, Inc., Pfizer Inc. and National Resilience, Inc. Dr. Gottlieb was previously employed as a Commissioner by US Food & Drug Administration, a Managing Director by T.R. Winston & Co., Inc., an Independent Director by CombiMatrix Corp., and an Analyst by Alex. Brown & Sons, Inc. He also served on the board at EMI, Inc., Tolero Pharmaceuticals, Inc., Gradalis, Inc., Aptiv Solutions, Inc., American Pathology Partners, Inc., Bravo Health, Inc., MedAvante, Inc., Molecular Insight Pharmaceuticals, Inc., Aseko, Inc. and Targeted Medical Pharma, Inc. He received his undergraduate degree from Wesleyan University and a doctorate degree from Icah School of Medicine at Mount Sinai.
|05/26/2021||881||Award at $0 per share.||0|
|05/27/2020||963||Award at $0 per share.||0|
|02/04/2020||395||Award at $0 per share.||0|